Form 4: Inspire Medical Director Acquires Shares
Insider Transaction Disclosure
Inspire Medical Systems Director Casey M. Tansey acquired 221 shares of common stock as part of compensation.
Summary
- Casey M. Tansey, a Director at Inspire Medical Systems, Inc. (INSP), acquired 221 shares of common stock.
- The transaction occurred on October 14, 2025, with shares valued at $78.84 each.
- These shares were received in lieu of cash fees, consistent with the Company's Non-Employee Director Compensation Policy.
- Following this transaction, Casey M. Tansey directly beneficially owns 22,235 shares of common stock.
- Additionally, 500 shares are indirectly held by The Kimberly Tansey Irrevocable Trust, and another 500 shares are indirectly held by The Kylie Tansey Irrevocable Trust.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of an insider transaction, indicating a neutral sentiment as it does not convey positive or negative operational or financial news for the company.
Positives
- A Director's acquisition of shares, even as compensation, can signal alignment of interests with shareholders.
Future Outlook
This filing is a disclosure of an insider transaction and does not contain any forward-looking statements or guidance regarding the company's future performance.
Industry Context
This is a routine insider transaction disclosure and does not provide information relevant to broader industry trends or competitor analysis.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy Reference | The acquisition of shares was made pursuant to the Company's Non-Employee Director Compensation Policy, indicating a standard practice for director remuneration. | N/A | This reflects a standard corporate governance practice for compensating non-employee directors with equity, aligning their interests with shareholders. |
Stakeholder Impact
- Shareholders: The transaction represents a minor increase in a director's beneficial ownership, potentially signaling confidence in the company, though it is part of a compensation plan rather than an open market purchase.
Key Dates
| Date | Description |
|---|---|
| 10/14/2025 | Date of transaction where Casey M. Tansey acquired shares. |
| 10/16/2025 | Date the Form 4 was signed by Bryan Phillips, Attorney-in-Fact for Casey M. Tansey. |
Keywords
Inspire Medical Systems, INSP, Form 4, Insider Trading, Director Compensation, Stock Acquisition, Casey M. Tansey
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.